Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unum Business Ventures is the corporate venture investment arm of Unum Group, a U.S. employee benefits and insurance company. The unit appears to invest primarily in early-stage companies that are strategically relevant to Unum, with activity spanning healthtech, insurtech and related workplace-benefits technology rather than developing therapeutics itself. Available public sources indicate investments in companies such as Nayya, pumpspotting and Tuned. Because it functions as an investment vehicle rather than an operating drug-development company, it does not have a therapeutic pipeline, clinical-stage assets or disclosed molecular targets. For biotech and healthcare analysts, the most relevant lens is as a corporate-backed healthtech investor connected to Unum's benefits, leave-management and workforce health ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unum Business Ventures.